Terra Lord Parten

Terra Lord Parten focuses her practice on regulatory, transactional and corporate matters with an emphasis on the healthcare industry. Her regulatory practice includes issues relating to Stark and anti-kickback compliance; Medicare and Medicaid enrollment, billing and reimbursement; Medicare fraud and abuse laws; Clinical Laboratory Improvement Amendments (CLIA), Health Insurance Portability and Accountability Act (HIPAA), Emergency Medical Treatment and Active Labor Act (EMTALA), and other federal and state regulatory requirements; and licensure and accreditation.

Terra’s transactional and corporate practice includes mergers; stock and asset acquisitions; reorganization and recapitalization transactions; corporate governance and formation issues; preparation and negotiation of management agreements, professional services agreements, and employment agreements; and other general business matters.

Terra earned her Juris Doctor in 2010 from the University of Oklahoma College of Law, where she graduated with highest honors and was named to the Order of the Coif. She was a recipient of the Comfort Scholarship and earned American Jurisprudence awards in Antitrust II, Conflicts of Law, Criminal Law, Criminal Procedure, Federal Securities Regulation, Intellectual Property, Mergers and Acquisitions, Secured Transactions, and Torts II.

While in law school, Terra served as note editor for the Oklahoma Law Review and is the author of “Closing Loopholes or Creating More? Why a Narrow Application of SORNA Threatens to Defeat the Statute’s Purpose,” Vol. 62, No. 2 Oklahoma Law Review (2010).  She also served on the Dean’s Council and spent time working for the Federal Judicial Center in Washington, D.C.

• Represented a large healthcare company in reorganizing and simplifying its capitalization and organizational structure through a series of mergers and other related transactions including, among other things, a private securities offering and amendment of existing credit facility.
• Represented the management and employees of a 77-store grocery chain in acquiring the company via an employee stock ownership plan (ESOP) from the second-largest retailer-owned grocery wholesaler in the United States.
• Serve as counsel to rural hospital in connection with ongoing compliance matters, including conducting training and preparing policies and procedures, under its corporate integrity agreement with the Office of the Inspector General of the U.S. Department of Health and Human Services.
• Represented healthcare development company in the sale of independent diagnostic testing facilities and radiation therapy centers to large hospital systems.
• Represented a public educational software company based in Oklahoma City in a going-private transaction.
• Represented shareholders of an Oklahoma-based industrial supply distribution company in the sale of stock to a private equity fund.
• Represented broadcasting company in complex recapitalization transaction.
• Represented research institute in developing policies and procedures to comply with requirements of Health and Human Services (HHS) and Food and Drug Administration (FDA), institutional review boards, National Institute of Health (NIH), and other regulations.
• Provide ongoing regulatory and transactional counsel to numerous hospitals, ambulatory surgery centers, independent diagnostic testing facilities, clinics and other healthcare providers.
• Representation of hospitals and physician groups in connection with False Claims Act lawsuits, overpayments, audits and appeals for both government and commercial payers.
• Representation of hospitals in obtaining Medicare provider-based status for outpatient clinics.